======= LSM2 ======= == Gene Information == * **Official Symbol**: LSM2 * **Official Name**: LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57819|57819]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y333|Q9Y333]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LSM2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LSM2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607282|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds specifically to the 3'-terminal U-tract of U6 snRNA. May be involved in pre-mRNA splicing. |LSM| |Lsm1-7-Pat1 complex| |Lsm2-8 complex| |U6 snRNP| |U6 snRNA binding| |Ral GTPase binding| |U4/U6 x U5 tri-snRNP complex| |exonucleolytic catabolism of deadenylated mRNA| |nuclear-transcribed mRNA catabolic process, exonucleolytic| |U2-type precatalytic spliceosome| |nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay| |catalytic step 2 spliceosome| |P-body| |nuclear-transcribed mRNA catabolic process| |mRNA catabolic process| |RNA catabolic process| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |nucleobase-containing compound catabolic process| |RNA splicing| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |mRNA processing| |organic cyclic compound catabolic process| |mRNA metabolic process| |RNA processing| |cellular macromolecule catabolic process| |macromolecule catabolic process| |RNA binding| |RNA metabolic process| |negative regulation of gene expression| |organic substance catabolic process| |cellular catabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.92| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.91| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|-1.74| |[[:results:exp303|39°C R06 exp303]]|1.83| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.84| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 739/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1720 * **Expression level (log2 read counts)**: 4.95 {{:chemogenomics:nalm6 dist.png?nolink |}}